Eleva GmbH
- Address
- Hans-Bunte-Strasse 19, Bruehl
Sponsor Overview
Specializations
Complement-mediated kidney disease
Eleva GmbH is active in research related to C3 glomerulopathy, a rare form of kidney disease driven by dysregulation of the complement system. Its clinical research interest centers on conditions affecting the renal filtration process and immune-mediated damage within the kidneys.
- C3 glomerulopathy
- Complement dysregulation
- Renal inflammation
- Glomerular injury
The sponsor’s research activity is focused on rare nephrology and the biological mechanisms underlying progressive glomerular disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of CPV-104 Pharmacokinetics, Safety, and Tolerability in Healthy Subjects and Patients with C3 Glomerulopathy |  Austria Belgium Czechia France Greece Latvia Lithuania Portugal Spain Sweden The Netherlands | Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 15 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
Partnered Research Centres
15 centres- Address
- De Boelelaan 1117, 1081 HV Amsterdam
- Address
- 1 Place Du Docteur Joseph Baylac, 31300 Toulouse
- Address
- Hippokrateslaan 10, Batiment 54, 1200 Woluwe-Saint-Lambert
- Address
- Videnska 800, Krc, 140 00 Prague
- Address
- Calle De Cartagena 340-350, 08025 Barcelona
- Address
- Rua da Beneficência, nº8, 1069-166 Lisbon
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Eleva GmbH.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.